Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin

Vani P Sanon,1 Shalin Patel,1 Saurabh Sanon,2 Ruben Rodriguez,1 Son V Pham,1 Robert Chilton1 1Division of Cardiology, University of Texas Health Science Center at San Antonio, Audie L Murphy VA Hospital, San Antonio, TX, 2Interventional Cardiology-Structural Heart Disease, Cardiology Consultants at...

Full description

Bibliographic Details
Main Authors: Sanon VP, Patel S, Sanon S, Rodriguez R, Pham SV, Chilton R
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
SGLT2 inhibitors
Diabetes
Cardiovascular mortality
Heart failure
Hypertension
Online Access:https://www.dovepress.com/differential-cardiovascular-profiles-of-sodium-glucose-cotransporter-2-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/differential-cardiovascular-profiles-of-sodium-glucose-cotransporter-2-peer-reviewed-article-TCRM

Similar Items